Navigation Links
West Announces Third Quarter 2011 Dividend
Date:5/6/2011

LIONVILLE, Pa., May 6, 2011 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors has approved payment of the third-quarter 2011 cash dividend of $0.17 per share. The dividend will be paid on August 3, 2011 to shareholders of record on July 20, 2011.

In addition, West announced that its shareholders approved each of the proposals presented at its May 3, 2011 annual meeting, as recommended by its Board of Directors.  These included a proposal to declassify the Board and, as a result, each of the Company's directors will be elected annually beginning in 2012.

About WestWest is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. The Company also provides products with application to the personal care, food and beverage markets. Headquartered in Lionville, Pennsylvania, West supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at www.westpharma.com.Contacts:

Investors and Financial Media:West Pharmaceutical Services, Inc.

Westwicke PartnersMichael A. Anderson

John Woolford/Stefan LorenVice President and Treasurer

(443) 213-0506/0507(610) 594-3345
'/>"/>

SOURCE West Pharmaceutical Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2017)... N.J. , Sept. 5, 2017  Getinge, ... has created a vibrant charitable donation program -- ... and support congenital heart defect research by The ... providers and the general public are encouraged to ... and submit the completed artwork to the gallery ...
(Date:9/1/2017)... Michael Penna , President and CEO ... for growth in his response to the July 13, ... seeking a buyer for eMDs. Penna,s company, Complete HealthCare ... Value Added Reseller and national leader in the independent ... "As the healthcare market continues to dictate consolidation, healthcare ...
(Date:8/31/2017)... PM360,s annual Innovations Issue, published in ... innovations happening across the industry. Established six years ago, ... providing a comprehensive look at the newest and most ... innovative companies, startups, divisions, products, services, and strategies from ... "Everyone in this industry wants to do better—in all ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... ... Recognising that in today’s busy world consumers are often ... in just three weeks. Setting the groundwork for a healthier lifestyle, Leany Greeny ... work and family schedules, participants can lose up to 15lbs during the program ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... Houston, Texas, ... team took Friday, September 8, and Monday, September 11, off work and rolled up ... Baptist Church before heading to local homes to start the process of rebuilding. , ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Financial Favor of God; Second Edition”: a ... Second Edition” is the creation of published author, Brooks Rathell. , “We typically hear ... to you about the financial favor of God. Not only does it exist, but ...
(Date:9/19/2017)... ... , ... Only a few physicians were selected to receive the prestigious 2016 ... MD, FACS . The founder and medical director of Clevens Face and Body ... Yale, Harvard and the University of Michigan. He has served patients throughout Central Florida ...
(Date:9/19/2017)... ... September 19, 2017 , ... Peter Chandonait, Abt Associates Principal ... Initiative (PMI) Africa Indoor Residual Spraying (AIRS) Project , has been named the ... to Action Award, a USAID Catalyst Award, recognizes USAID staff and implementing partners ...
Breaking Medicine News(10 mins):